U.S. Markets closed
  • S&P Futures

    3,898.25
    -18.00 (-0.46%)
     
  • Dow Futures

    31,352.00
    -135.00 (-0.43%)
     
  • Nasdaq Futures

    12,085.75
    -54.75 (-0.45%)
     
  • Russell 2000 Futures

    1,753.10
    -8.60 (-0.49%)
     
  • Crude Oil

    105.91
    -1.71 (-1.59%)
     
  • Gold

    1,830.80
    +0.50 (+0.03%)
     
  • Silver

    21.11
    -0.01 (-0.05%)
     
  • EUR/USD

    1.0563
    +0.0004 (+0.0423%)
     
  • 10-Yr Bond

    3.1250
    +0.0570 (+1.86%)
     
  • Vix

    27.23
    -1.82 (-6.27%)
     
  • GBP/USD

    1.2277
    +0.0007 (+0.0589%)
     
  • USD/JPY

    134.5430
    -0.6270 (-0.4639%)
     
  • BTC-USD

    21,052.20
    -413.22 (-1.93%)
     
  • CMC Crypto 200

    458.45
    +4.55 (+1.00%)
     
  • FTSE 100

    7,208.81
    +188.36 (+2.68%)
     
  • Nikkei 225

    26,748.09
    +256.12 (+0.97%)
     

Ionis to hold third quarter 2021 financial results webcast

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

Webcast scheduled for Wednesday, November 3 at 11:30 a.m. Eastern Time

CARLSBAD, Calif., Oct. 20, 2021 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, November 3rd at 11:30 a.m. Eastern Time to discuss its third quarter 2021 financial results and report on pipeline and business progress.

(PRNewsfoto/Ionis Pharmaceuticals, Inc.)
(PRNewsfoto/Ionis Pharmaceuticals, Inc.)

Interested parties may access the webcast at https://ir.ionispharma.com/events-and-presentations/upcoming-events. A webcast replay will be available for a limited time at the same address.

About Ionis Pharmaceuticals, Inc.
For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry leading neurological and cardiometabolic franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming one of the most successful biotechnology companies.

To learn more about Ionis visit www.ionispharma.com and follow us on Twitter @ionispharma.

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/ionis-to-hold-third-quarter-2021-financial-results-webcast-301404082.html

SOURCE Ionis Pharmaceuticals, Inc.